ORF_ID	Contig	Start	Stop	Orientation	Cut_Off	Pass_Bitscore	Best_Hit_Bitscore	Best_Hit_ARO	Best_Identities	ARO	Model_type	SNPs_in_Best_Hit_ARO	Other_SNPs	Drug Class	Resistance Mechanism	AMR Gene Family	Predicted_DNA	Predicted_Protein	CARD_Protein_Sequence	Percentage Length of Reference Sequence	ID	Model_ID	Nudged	Note
scaffold_1_198 # 244863 # 245108 # 1 # ID=1_198;partial=00;start_type=TTG;rbs_motif=GGAGG;rbs_spacer=3-4bp;gc_cont=0.561	scaffold_1_198 	244863	245108	+	Strict	585	21.557	LAP-2	100.0	3004826	protein homolog model	n/a	n/a	fluoroquinolone antibiotic; aminoglycoside antibiotic; tetracycline antibiotic; rifamycin antibiotic	antibiotic inactivation	LAP beta-lactamase	TTGACCCCAGACGTAGCTGGCGATCATGGTTCCCGGGGCACCTGGGACATCGACGCCGTACGAGGGGTAGACACAGCGGCGGATGGGAAGGTCGGTAAAGGATTGACCACCCTTGAAAGGACCGGTGGCGAGGTTCTCCCACCTGCAATTAGCACATTAGTCGAAGCCCCGAGTCTGATACTATGGCCGAAAGTAGCTCACCAGCGAGTCTTGAACTTGAACCCAATCTTTGTCGAAGGATCGTAG	MTPDVAGDHGSRGTWDIDAVRGVDTAADGKVGKGLTTLERTGGEVLPPAISTLVEAPSLILWPKVAHQRVLNLNPIFVEGS	MKKIRLIIISLLAGMCTPALSTPVNVTDTIQSTEDHIKGRVGFTEIDFLSGKVLSSHRREERFPMMSTFKVLLCGAILVRVDKGLEQLERRITYNKHDLDDYSPLTSQHIADGMTVSELCNAAITTSDNTAANLLLSTIGGPEGLTHFLRSTGDSYTRLDRHEPSLNEAKPGDERDTTTPAAMAQTLQKLLNESVLTEKSRKKLISWMQEDKVGGPLFRSVLPAGWMIADKTGAGDHGSRGIVALLGPGGKPSRIVVLYITNTHSSMNELNEHIAGIGDSVIKNW	28.42	gnl|BL_ORD_ID|2496|hsp_num:0	3621	True	loose hit with at least 95 percent identity pushed strict
scaffold_4_382 # 404806 # 404937 # 1 # ID=4_382;partial=00;start_type=ATG;rbs_motif=GGAGG;rbs_spacer=5-10bp;gc_cont=0.515	scaffold_4_382 	404806	404937	+	Strict	500	20.4014	Escherichia coli ampH beta-lactamase	100.0	3004612	protein homolog model	n/a	n/a	cephalosporin; penam	antibiotic inactivation	ampC-type beta-lactamase	ATGTATGATGCCTTGGGTTTAGGATGGGGGAACAGTCTTCTGGGCTTCATGTCCTTGGCACTGGTGCCGGTACCTGTTGGTCTGTTTTTCTACGGGGGCATGATTCGGAAGAGATTCGATCCTGTGCTGTGA	MYDALGLGWGNSLLGFMSLALVPVPVGLFFYGGMIRKRFDPVL	MKRSLLFSAVLCAASLTSVHAAQPITEPEFASDIVDRYADHIFYGSGATGMALVVIDGNQRVFRSYGETRPGNNVRPQLDSVVRIASLTKLMTSEMLVKLLDQGTVKLNDPLSKYAPPGARVPTYNGTPITLVNLATHTSALPREQPGGAAHRPVFVWPTREQRWKYLSTAKLKAAPGSQAAYSNLAFDLLADALANASGKPYTQLFEEQITRPLGMKDTTYTPSPDQCRRLMVAERGASPCNNTLAAIGSGGVYSTPGDMMRWMQQYLSSDFYQRSNQADRMQTLIYQRAQFTKVIGMDVPGKADALGLGWVYMAPKEGRPGIIQKTGGGGGFITYMAMIPQKNIGAFVVVTRSPLTRFKNMSDGINDLVTELSGNKPLVIPAS	11.17	gnl|BL_ORD_ID|2079|hsp_num:0	3307	True	loose hit with at least 95 percent identity pushed strict
scaffold_5_287 # 376155 # 376457 # -1 # ID=5_287;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.535	scaffold_5_287 	376155	376457	-	Strict	800	22.3274	PDC-384	100.0	3005283	protein homolog model	n/a	n/a	monobactam; carbapenem; cephalosporin	antibiotic inactivation	PDC beta-lactamase	ATGGCTCCTCTTGTTTGGCTCATTACGGGAAGCACCTCAGGCTTTGGCGCCGAGTTTGTCAAGGCACTCCTTGCTAAAGGAGATAAAGTCATTGCTACAGCTCGCGACACCTCGAAGATAGCCCACTTTCGTGAAGCTGGCGCGGCTGTACTGAAATTGGATCTCCTTGCCGACCAGGCCGAGTTCGACAAGGTGGCCCAGGACAGCCTCAGCATCTATGGCAGTGTTGATGTGCTAGTCAACAATGCAGGCTACTCCCACTTCGGAACCATGGAGGACGACAGGTTAGTTGCTCTCACTTGA	MAPLVWLITGSTSGFGAEFVKALLAKGDKVIATARDTSKIAHFREAGAAVLKLDLLADQAEFDKVAQDSLSIYGSVDVLVNNAGYSHFGTMEDDRLVALT	MRDTRFPCLCGIAASTLLFAATPAIAGEAPADRLKALVDAAVQPVMKANDIPGLAVAISLKGEPHYFSYGLASKEDGRRVTPETLFEIGSVSKTFTATLAGYALAQDKMRLDDRASKHWPALQGSRFDDISLLDLATYTAGGLPLQFPDSVQKDRAQIRDYYRQWQPTYAPGSQRLYSNPSIGLFGYLAARSLGQPFERLMEQQLFPALGLEQTHLDVPEAALAQYAQGYGKDDRPLRVGPGPLDAEGYGVKTSAADLLRFVDANLHPERLDRPWAQALDATHRGYYKVGDMTQGLGWEAYDWPISLKRLQAGNSTPMAPQPHRIARLPAPQALEGQRLLNKTGSTSGFGAYVAFVPGRDLGLVILANRNYPNAERVKIAYAILSGLEQQAKVPLKR	25.19	gnl|BL_ORD_ID|3050|hsp_num:0	4011	True	loose hit with at least 95 percent identity pushed strict
scaffold_7_169 # 244079 # 244207 # 1 # ID=7_169;partial=00;start_type=ATG;rbs_motif=AGGA;rbs_spacer=5-10bp;gc_cont=0.527	scaffold_7_169 	244079	244207	+	Strict	350	20.0162	Campylobacter coli chloramphenicol acetyltransferase	100.0	3004454	protein homolog model	n/a	n/a	phenicol antibiotic	antibiotic inactivation	chloramphenicol acetyltransferase (CAT)	ATGGAGTGGGAGGATTTTCCGCGAGGACATGTTGGCAACACACACGCCGTAACCTTGTCGGCCGATGCAGCAGAGCCTGAGTTTGGGAATACCCCCTGCGGACTCCGATTGCATATTTTTCATGGTTAA	MEWEDFPRGHVGNTHAVTLSADAAEPEFGNTPCGLRLHIFHG	MQFTKIDINNWTRKEYFDHYFGNTPCTYSMTVKLDISKLKKDGKKLYPTLLYGVTTIINRHEEFRTALDENGQVGVFSEMLPCYTVFHKETETFSSIWTEFTADYTEFLQNYQKDIDAFGERMGMSAKPNPPENTFPVSMIPWTSFEGFNLNLKKGYDYLLPIFTFGKYYEEGGKYYIPLSIQVHHAVCDGFHVCRFLDELQDLLNK	20.29	gnl|BL_ORD_ID|2566|hsp_num:0	2893	True	loose hit with at least 95 percent identity pushed strict
scaffold_12_440 # 579500 # 579595 # -1 # ID=12_440;partial=01;start_type=Edge;rbs_motif=None;rbs_spacer=None;gc_cont=0.427	scaffold_12_440 	579500	579595	-	Strict	550	20.0162	LRA-9	100.0	3002488	protein homolog model	n/a	n/a	cephalosporin; penam	antibiotic inactivation	subclass B3 LRA beta-lactamase	GAATCAGAGACATCTTCAGACTGCAACATGATTATTGCGGTTATCATCCGCAAGGAAGAGTTTGATTATCGCCGTCCTTTGGTAGACTCCACCTGA	ESETSSDCNMIIAVIIRKEEFDYRRPLVDST	MKLRYLLAAALLMTTASAFGADAPKRLPVNITNKEWLMPFPGFKIVGNMYYVGTYDLGCYLIDTGAGLILVNTGIMGSYPLMKASIESLGFKTSDIKIITATHGHSDHVGDIALFKKDAPGATVYMSERDVESLESGGNFDYRRPAPEGRGGLVYDPIHVDVKTKPGDHIKLGNVDMTVLQAYGHTPGATSFSFQQTDAGKTYNVLIVNMNGINAGVKLLGSPHYPTIVEDFKNTIDMQATYKPDIWVSSHSGQFNLHQVYKPGDAYNPARFGDLAAYQKKIATAKANYEKQLAEERAAAK	10.30	gnl|BL_ORD_ID|103|hsp_num:0	118	True	loose hit with at least 95 percent identity pushed strict
scaffold_14_57 # 63945 # 64313 # -1 # ID=14_57;partial=00;start_type=ATG;rbs_motif=GGA/GAG/AGG;rbs_spacer=11-12bp;gc_cont=0.534	scaffold_14_57 	63945	64313	-	Strict	700	23.0978	Escherichia coli ampC beta-lactamase	100.0	3004290	protein homolog model	n/a	n/a	cephalosporin; penam	antibiotic inactivation	ampC-type beta-lactamase	ATGGTTCTTGAATCGAATGAGAGGGTGACGACGAGACACCATGACACGGCAAGCTTTCTGAGAGCCATCCTCGAATGTCGGTGTTCCGCCAATGATCTGCAGCAAGTTCACGAGCTTTTTGAAGCTAAAGCCGGAGCTGGAGCTAGAACCAAGCACACACCACCGACACCAGCAGTGCGAAGGGACCACAGTAAGGCATGTGTCATCCCACGGACGCACGACCATCAACAGCAACAAGTGGCCACTGGCCATGCCAGGATCGCGGGGTACGAAACTGAGGCATATGTAGCCGAGACTTCCCAACACAGGGTTAACAATACGCGGATTATGGGCATGCAAAGAGCGCTCGTACGGTGTAACCTCAGGTAA	MVLESNERVTTRHHDTASFLRAILECRCSANDLQQVHELFEAKAGAGARTKHTPPTPAVRRDHSKACVIPRTHDHQQQQVATGHARIAGYETEAYVAETSQHRVNNTRIMGMQRALVRCNLR	MFKTTLCALLITASCSTFAAPQQINDIVHRTITPLIEQQKIPGMAVAVIYQGKPYYFTWGYADIAKKQPVTQQTLFELGSVSKTFTGVLGGDAIARGEIKLSDPTTKYWPELTAKQWNGITLLHLATYTAGGLPLQVPDEVKSSSDLLRFYQNWQPAWAPGTQRLYANSSIGLFGALAVKPSGLSFEQAMQTRVFQPLKLNHTWINVPPAEEKNYAWGYREGKAVHVSPGALDAEAYGVKSTIEDMARWVQSNLKPLDINEKTLQQGIQLAQSRYWQTGDMYQGLGWEMLDWPVNPDSIINGSDNKIALAARPVKAITPPTPAVRASWVHKTGATGGFGSYVAFIPEKELGIVMLANKNYPNPARVDAAWQILNALQ	32.36	gnl|BL_ORD_ID|2497|hsp_num:0	2843	True	loose hit with at least 95 percent identity pushed strict
scaffold_21_88 # 71772 # 71924 # 1 # ID=21_88;partial=00;start_type=ATG;rbs_motif=GGA/GAG/AGG;rbs_spacer=11-12bp;gc_cont=0.418	scaffold_21_88 	71772	71924	+	Strict	500	20.4014	cfrC	100.0	3004146	protein homolog model	n/a	n/a	lincosamide antibiotic; streptogramin antibiotic; oxazolidinone antibiotic; phenicol antibiotic	antibiotic target alteration	Cfr 23S ribosomal RNA methyltransferase	ATGAACTTGAGGATTTATAAGCAAGGGTGGGAGGTTGGCAAGCTTCTGGCTCGCTGGTCGAACGTGGTGGTCCGCATTATACATGTTTGCATTATTCTGTTGGAACACATGATATTTACAGACCACCTGTTGCTAATACAAATATACAAATGA	MNLRIYKQGWEVGKLLARWSNVVVRIIHVCIILLEHMIFTDHLLLIQIYK	MKQTKTKYGKMKQIASNLKLPDYRYEQLTKAIFHQRIDNFHDMHILPKALRIALVNEFGKNVSSVTPIFSQDSKQAQKLLFELTDGERIEAVGLKYKQGWESFCISSQCGCSFGCRFCATGSAGFKRNLTADEITDQLLYFYFNDHRLNSISFMGMGEAFANPELFDAVKILTDQNLFGLSQRRITISTIGIIPGIQRLTKEFPQVNLAFSLHSPFESQRSDLMPINKRFPLNEVMKTLDEHIIHTGRRVFIAYIMLEGINDSKEHAEAIIGLLRNRGSWEHLYHIDLIPYNSTDKTTFKFQSSSAIKQFCSTLKKASISATVRTQFGSEISAACGQLCYENEL	14.53	gnl|BL_ORD_ID|2479|hsp_num:0	2800	True	loose hit with at least 95 percent identity pushed strict
scaffold_28_146 # 231990 # 232478 # -1 # ID=28_146;partial=00;start_type=TTG;rbs_motif=GGAG/GAGG;rbs_spacer=5-10bp;gc_cont=0.509	scaffold_28_146 	231990	232478	-	Strict	500	23.483	ANT(4')-Ia	100.0	3002623	protein homolog model	n/a	n/a	aminoglycoside antibiotic	antibiotic inactivation	ANT(4')	TTGACCGCAGTCAATGATCCAAGAGTTCTGCGATACTGCATTGAACAGCATGAGGGCCTCGTCACAGACATTAAGGCCCTTCTCGGACCAAAGAACTTTACCACAATTCTCGATTTCCAACCAATCCCGTCATACTTTGCAGATATTGGAGTGCAGAAAGGGGGCAACATGCTCGGGCTCGAGCGAGACTCGCGCAACAAGGTTCTTTTCGTAATGGGAGTGACTCTACTAGGATCAAACAGCGAGGAGCTCTACCCTCGGGTTTACCAGCAGGTTGCAGCCGCGAACAAGAGAATTGAGGACTTCTCCAAGTCGATTGGCAGCGACACTGAGCTCAGGTACCTTCCATATGCGGATTCGAGGCAGGATGCAATTGGAAGTTACGGAAAAGCCAATGTGGAGCACATCCGAAGAGTTGCGGAGGAATATGACCCCGAAGGCTTCTTCCAGTACAGGGTTCCTGGTGGCTTCAAGATCAGTCGAGTTTAA	MTAVNDPRVLRYCIEQHEGLVTDIKALLGPKNFTTILDFQPIPSYFADIGVQKGGNMLGLERDSRNKVLFVMGVTLLGSNSEELYPRVYQQVAAANKRIEDFSKSIGSDTELRYLPYADSRQDAIGSYGKANVEHIRRVAEEYDPEGFFQYRVPGGFKISRV	MNMNGPASMAQKERLQTCQEIAKRLHEVYGNDVLAIGVYGSVSRGTDGPFSDIEMFCVLRDSAETVDKSYEWSAGPWKAEVNVCSASILLKDAATVEDRWPLTHGPYFSPLRLYDPEGFFQRLRLAAESPTKEDFRQAIHEILVGEMYEYVGKLRNVNRNGPSTYLPSLALRFAHYGAMLIGLHNQTLFSTGAMVLPEALKLPHRPKGFDHVAELAMSGDLAQPAKIVSACEDFWKGLVAWAAEHDYVIHSKRIPF	63.28	gnl|BL_ORD_ID|1637|hsp_num:0	1737	True	loose hit with at least 95 percent identity pushed strict
scaffold_44_59 # 61352 # 61834 # 1 # ID=44_59;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.499	scaffold_44_59 	61352	61834	+	Strict	500	26.1794	TEM-31	100.0	3000901	protein homolog model	n/a	n/a	monobactam; cephalosporin; penam; penem	antibiotic inactivation	TEM beta-lactamase	ATGTGGGGGACACACACAACATTGTTACATCGCTGGGTGATGGATGGTGGGGTCCACGGGTGTTTGTGGAGGCCACGTCCGGCGAGCGTTCATCCTGGATGTGGAGGAGTTCCGGTGCCCGCGCCGGTGATGGGCGCGGGGGAACGGGGATCATGCGGTATTCACATGAGACGTAGAGTGAGTGAGCAACGCATCATCGAGTGTAACTTCCAACGAGTTCATAACTGCAAAGGTTCTTTTACTTCAAAACAGGCCCTGAGTGTACTCTGTATAGTCACAGATGCACACGCCCTGCTGTATCTTACATTTGACCTGAAGCACATATCATTACACGTACGGATACACCGTACATCAAATTTACCAGATAATTATCTTCGCGTGAACCCTCCCGAGCCTCTTTTTTTTTTTTTTTTTTCGCAATATCCCCATAACAATTGGGTGACCGAACCTTCTTTGACAAGCACACCACCCCCTCCTGACTAG	MWGTHTTLLHRWVMDGGVHGCLWRPRPASVHPGCGGVPVPAPVMGAGERGSCGIHMRRRVSEQRIIECNFQRVHNCKGSFTSKQALSVLCIVTDAHALLYLTFDLKHISLHVRIHRTSNLPDNYLRVNPPEPLFFFFFSQYPHNNWVTEPSLTSTPPPPD	MSIQHFRVALIPFFAAFCLPVFAHPETLVKVKDAEDQLGARVGYIELDLNSGKILESFRPEERFPMMSTFKVLLCGAVLSRVDAGQEQLGRRIHYSQNDLVEYSPVTEKHLTDGMTVRELCSAAITMSDNTAANLLLTTIGGPKELTAFLHNMGDHVTRLDRWEPELNEAIPNDERDTTMPAAMATTLRKLLTGELLTLASRQQLIDWMEADKVAGPLLRSALPAGWFIADKSGAGERGSCGIIAALGPDGKPSRIVVIYTTGSQATMDERNRQIAEIGASLIKHW	55.94	gnl|BL_ORD_ID|3018|hsp_num:0	3978	True	loose hit with at least 95 percent identity pushed strict
scaffold_48_354 # 343047 # 343358 # -1 # ID=48_354;partial=00;start_type=ATG;rbs_motif=GGAG/GAGG;rbs_spacer=5-10bp;gc_cont=0.564	scaffold_48_354 	343047	343358	-	Strict	920	23.0978	OpmD	100.0	3000809	protein homolog model	n/a	n/a	fluoroquinolone antibiotic; tetracycline antibiotic; acridine dye; disinfecting agents and intercalating dyes	antibiotic efflux	resistance-nodulation-cell division (RND) antibiotic efflux pump	ATGGGTGTGGGTGTGGGTGTACGGTTTTGTTCACGGCGAGGCTATCGTGGGGAAGGAAGCGTTCTCGGGGACGAAGAGGAAATGACGAGGGTCTGCTGTTGGCGTGTCGTGCTTTGCTGGGCAAGGAAGGTGGTGTTTCGAATTGGCCTTCCGTGCTGGGTCGGGGGGAACGTCGCTTTGGTGGGGTTCGTGGATCGGAGGTCACGGCGGGAAGGAGTTGAGGTAGAAAGAACGGTGAGGGGTAAAAAGTATTTAGTGGTGCCCTGGTGGTCGTTCTTTTTCTCAAGGTGCGTTATCGTGGGGGGGAGGTAA	MGVGVGVRFCSRRGYRGEGSVLGDEEEMTRVCCWRVVLCWARKVVFRIGLPCWVGGNVALVGFVDRRSRREGVEVERTVRGKKYLVVPWWSFFFSRCVIVGGR	MKRSYPNLSRLALALAVGTGLAACSVGPDYQRPQSPPPRVASEHLGEFSGERREAPWWSFFDDPQLVRLVDQALARNHDIREARANLRSARALFDDRWLDQLPQVTSQAGYSRSIEQQLDYDGEPRRRLAESYRAGFDAQWEIDLFGRLGRLSDAALARAEAADADLRLVRLSIAADTARAYFEIQGYQRRLDVARAQVRSWRDTLELTRSSLQLGSGLPEDVENAQANLLRSEAAIPPLTTALESARYRLDVLRGEAPGSGAPILDGGAAAPLAKNLPLGDVDRLILQRPDVVSAERQLAASTEDVGAATAELYPRLDLGGFIGFFALRSGDLGSASRAFELAPSVSWPAFRLGNVRARLRAVEAQSDAALARYQRSLLLAQEDVGNALNQLAEHQRRLVALFQSATHGANALEIANERYRAGAGSYLAVLENQRALYQIREELAQAETASFVNVIALYKALGWGSGDLAPGAGQLAAGETAGANR	21.15	gnl|BL_ORD_ID|410|hsp_num:0	442	True	loose hit with at least 95 percent identity pushed strict
scaffold_49_4 # 3792 # 3983 # -1 # ID=49_4;partial=00;start_type=ATG;rbs_motif=AGGA;rbs_spacer=5-10bp;gc_cont=0.479	scaffold_49_4 	3792	3983	-	Strict	570	21.1718	AAC(3)-IId	100.0	3004623	protein homolog model	n/a	n/a	aminoglycoside antibiotic	antibiotic inactivation	AAC(3)	ATGCTCCTAGATGTAGCAAAATTCAGGGCTATTCGCCACATGGGTGTCACTGACAAGAGAGATGAAATCATCGGGCAAATTGCCATTAACTTCAAAGAAGCTCTCGACGATGAGGCGCGAAGGACGAAATGGGAGTCTAAGATAGGTAGCATCTCTCAAAACCGCTCGGGCTGCAAGGAAGAAGACGATTAA	MLLDVAKFRAIRHMGVTDKRDEIIGQIAINFKEALDDEARRTKWESKIGSISQNRSGCKEEDD	MHTRKAITEALQKLGVQTGDLLMVHASLKAIGPVEGGAETVVAALRSAVGPTGTVMGYASWDRSPYEETLNGARLDDEARRTWLPFDPATAGTYRGFGLLNQFLVQAPGARRSAHPDASMVAVGPLAETLTEPHELGHALGEGSPVERFVRLGGKALLLGAPLNSVTALHYAEAVADIPNKRWVTYEMPMLGRDGEVAWKTASDYDSNGILDCFAIEGKPDAVETIANAYVKLGRHREGVVGFAQCYLFDAQDIVTFGVTYLEKHFGTTPIVPPHEAVERSCEPSG	22.03	gnl|BL_ORD_ID|2165|hsp_num:0	3322	True	loose hit with at least 95 percent identity pushed strict
scaffold_49_265 # 294624 # 294749 # -1 # ID=49_265;partial=00;start_type=ATG;rbs_motif=GGAG/GAGG;rbs_spacer=5-10bp;gc_cont=0.595	scaffold_49_265 	294624	294749	-	Strict	700	21.9422	EreB	100.0	3000363	protein homolog model	n/a	n/a	macrolide antibiotic	antibiotic inactivation	macrolide esterase	ATGGCTAGAGGATATGGCATTTCTGGTGGTGGGATGCAAGGCGGGAACTCTCAAGGGGGGGTGGGAAGGGTGAACGGGGGGCGCAAGACAGGGGTCGAGGGATGGGATGCCGAACGAGGTTGCTAA	MARGYGISGGGMQGGNSQGGVGRVNGGRKTGVEGWDAERGC	MRFEEWVKDKHIPFKLNHPDDNYDDFKPLRKIIGDTRVVALGENSHFIKEFFLLRHTLLRFFIEDLGFTTFAFEFGFAEGQIINNWIHGQGTDDEIGRFLKHFYYPEELKTTFLWLREYNKAAKEKITFLGIDIPRNGGSYLPNMEIVHDFFRTADKEALHIIDDAFNIAKKIDYFSTSQAALNLHELTDSEKCRLTSQLARVKVRLEAMAPIHIEKYGIDKYETILHYANGMIYLDYNIQAMSGFISGGGMQGDMGAKDKYMADSVLWHLKNPQSEQKVIVVAHNAHIQKTPILYDGFLSCLPMGQRLKNAIGDDYMSLGITSYSGHTAALYPEVDTKYGFRVDNFQLQEPNEGSVEKAISGCGVTNSFVFFRNIPEDLQSIPNMIRFDSIYMKAELEKAFDGIFQIEKSSVSEVVYE	9.79	gnl|BL_ORD_ID|1814|hsp_num:0	1921	True	loose hit with at least 95 percent identity pushed strict
scaffold_52_180 # 189459 # 189686 # -1 # ID=52_180;partial=00;start_type=ATG;rbs_motif=GGA/GAG/AGG;rbs_spacer=5-10bp;gc_cont=0.592	scaffold_52_180 	189459	189686	-	Strict	400	21.557	IMP-7	100.0	3002198	protein homolog model	n/a	n/a	carbapenem; cephalosporin; cephamycin; penam; penem	antibiotic inactivation	IMP beta-lactamase	ATGGTGGTGTTGGTCGTGCTGGTCCCTGTTCTGGCACGCCTGGGTCTGGTCGTTTTATTCCGTGTGCCTTATCCGGGTCCGGGACACCCACGCTGTGGGACGGAAACAGCTGAATTCTGCATATTCGCACGCGCCGCCTGTGTCTCTCTCTCTCGCACTCTGCCTTGCGCAGTGCTAAATTTTAGGGTAGAGAGAGGCGTACCGGGTGGTCGGGCGGAGAGCCTATAG	MVVLVVLVPVLARLGLVVLFRVPYPGPGHPRCGTETAEFCIFARAACVSLSRTLPCAVLNFRVERGVPGGRAESL	MKKLSVFFMFLFCSIAASGEALPDLKIEKLDEGVYVHTSFEEVNGWGVVPKHGLVVLVNTDAYLIDTPFTAKDTEKLVTWFVERGYKIKGSISSHFHSDSTGGIEWLNSQSIPTYASELTNELLKKDGKVQAKNSFSGASYWLVKKKIEIFYPGPGHTPDNVVVWLPEHRVLFGGCFVKPYGLGNLGDANLEAWPKSAKLLVSKYGKAKLVVPSHSEVGDASLLKRTLEQAVKGLNESKKLSKPSN	30.49	gnl|BL_ORD_ID|1341|hsp_num:0	1426	True	loose hit with at least 95 percent identity pushed strict
scaffold_53_79 # 77062 # 77253 # 1 # ID=53_79;partial=00;start_type=ATG;rbs_motif=GGA/GAG/AGG;rbs_spacer=5-10bp;gc_cont=0.531	scaffold_53_79 	77062	77253	+	Strict	500	22.7126	OXA-168	100.0	3001468	protein homolog model	n/a	n/a	carbapenem; cephalosporin; penam	antibiotic inactivation	OXA beta-lactamase	ATGCATGATTGCAGACTTACCGTGGTGGAAAAAGTCGAAGCAGCCATCGATCCAGATGCGCTCCTCCAGAATCTCAGGGGCTGGCTCGCCGGGTGGGTATTCAGGGTCGGAATTAACCATGATGGGTTAATGATGCCGTCGTCGATGGGAACTCGATGGGTTGCTGATTCTCCAGGATTCCAGGGACCTTAA	MHDCRLTVVEKVEAAIDPDALLQNLRGWLAGWVFRVGINHDGLMMPSSMGTRWVADSPGFQGP	MNKYFTCYVVASLFLSGCTVQHNLINETPSQIVQGHNQVIHQYFDEKNTSGVLVIQTDKKINLYGNALSRANTEYVPASTFKMLNALIGLENQKTDINEIFKWKGEKRSFTAWEKDMTLGEAMKLSAVPVYQELARRIGLDLMQKEVKRIGFGNAEIGQQVDNFWLVGPLKVTPIQEVEFVSQLAHTQLPFSEKVQANVKNMLLLEESNGYKIFGKTGWAMDIKPQVGWLAGWVEQPDGKIVAFALNMEMRSEMPASIRNELLMKSLKQLNII	23.08	gnl|BL_ORD_ID|1703|hsp_num:0	1802	True	loose hit with at least 95 percent identity pushed strict
scaffold_56_43 # 39764 # 39937 # 1 # ID=56_43;partial=00;start_type=ATG;rbs_motif=GGAG/GAGG;rbs_spacer=5-10bp;gc_cont=0.534	scaffold_56_43 	39764	39937	+	Strict	1300	20.7866	vanTC	100.0	3002970	protein homolog model	n/a	n/a	glycopeptide antibiotic	antibiotic target alteration	glycopeptide resistance gene cluster; vanT	ATGGCGACCAAATACTGGAATTGGCACCCTCATCGGTTCTTTGGGTACGACCTGAGACGGAAGGTGCCCTTTTTCATCGACATGGCCTGCGACGATTGTGCCGCCGAGGACCACACATCTGCGCTCGCTGCCACTTATTTCAGTCTAGCAGGTTCTAGCCCACTGAAATCGTAA	MATKYWNWHPHRFFGYDLRRKVPFFIDMACDDCAAEDHTSALAATYFSLAGSSPLKS	MKNKGIDQFRVIAAMMVVAIHCLPLHYLWPEGDILITLTIFRVAVPFFFMISGYYVFAELAVANSYPSRQRVFNFIKKQLKVYLLATLMFLPLALYSQTIGFDLPVGTLVQVLLVNGILYHLWYFPALITGSLLLTSLLIHVSFKKVFWLAAGLYLIGLGGDSWFGLIQQTPIEPFYTAVFHLLDGTRNGIFFTPLFLCLGVLVRKQSEKRSLSKTALFFLISLIGLLIESAYLHGFSIPKHDSMYLFLPVVLFFLFPLILRWHPHRTWKHPGQLSLWLYLLHPYTIAGTHFLSQKISILQNNLINYLVVLILTIGFICLFLRQKHSWFRHKQTTPVKRAVKEFSKTALLHNLQEIQRIISPKTKVMAVVKADAYGCGAKEVAPVLEQAGIDFFAVATIDEGIRLRKNAVKSPILVLGYTSPKRIKELRRYSLTQSIISEGHAVALSQRKVAIDCHLAIDTGMHRLGVTPTIDSILSIFDLPFLTISGVYSHLGSADRLNPDSMIRTQKQIACFDQILLELDQRQISYGITHLQSSYGILNYPDLNYDYVRPGILLTGSLSDTNEPTKQRVSLQPILTLKAQLITKRVVAKGEAIGYGQTAVANQETTVGVVSIGYCDGLPRSLSNQEFCLSYRGQSLPQIGLICMDMLLIDLSHCPTIPIESEIEILTDWSDTAEQVQTITNELICRIGPRVSARIK	8.17	gnl|BL_ORD_ID|692|hsp_num:0	734	True	loose hit with at least 95 percent identity pushed strict
scaffold_129_48 # 61598 # 61744 # -1 # ID=129_48;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.537	scaffold_129_48 	61598	61744	-	Strict	700	21.557	adeS	100.0	3000549	protein homolog model	n/a	n/a	glycylcycline; tetracycline antibiotic	antibiotic efflux	resistance-nodulation-cell division (RND) antibiotic efflux pump	ATGTGGCACATTAGTCCGGTCCCTGGCAGCCTGCAGAGTGCTGCCCAGGAAACTCCCGAGTGGTTCTCAATCTTGCCAGTGATAGACTTCGATCTGTGCGACATCGATTTCGGCAGCTCTCCGTACGCGATTGAGAAAGGTTGGTAG	MWHISPVPGSLQSAAQETPEWFSILPVIDFDLCDIDFGSSPYAIEKGW	MKSKLGISKQLFIALTIVNLSVTLFSIVLGYIIYNYAIEKGWISLSSFQQEDWTSFHFVDWIWLATVIFCGCIISLVIGMRLAKRFIVPINFLVEAAKKISHGDLSARAYDNRIHSAEMSELLYNFNDMAQKLEVSVKNAQVWNAAIAHELRTPITILQGRLQGIIDGVFKPDEVLFKSLLNQVEGLSHLVEDLRTLSLVENQQLRLNYELFDLKAVVEKVLKAFEDRLDQAKLVPELDLTSTPVYCDRRRIEQVLIALIDNAIRYSNAGKLKISSEVVADNWILKIEDEGPGIATEFRDDLFKPFFRLEESRNKEFGGTGLGLAVVHAIIVALKGTIKYSNQGSKSVFTIKISMGHEEMG	13.30	gnl|BL_ORD_ID|169|hsp_num:0	183	True	loose hit with at least 95 percent identity pushed strict
scaffold_137_60 # 59046 # 59156 # -1 # ID=137_60;partial=00;start_type=ATG;rbs_motif=GGA/GAG/AGG;rbs_spacer=5-10bp;gc_cont=0.505	scaffold_137_60 	59046	59156	-	Strict	1100	20.4014	oleB	100.0	3003036	protein homolog model	n/a	n/a	macrolide antibiotic; lincosamide antibiotic; streptogramin antibiotic; tetracycline antibiotic; oxazolidinone antibiotic; phenicol antibiotic; pleuromutilin antibiotic	antibiotic target protection	ABC-F ATP-binding cassette ribosomal protection protein	ATGGCGGCGTGTGTGGATATGATTAAAAACAAATGGTTTCAGGATCGTCGGCTTGGCTCGTTGAGCCCGCCCTTCAACTATCTTGCATGTGATGAGGAAGCCATGGATTGA	MAACVDMIKNKWFQDRRLGSLSPPFNYLACDEEAMD	MQNAHRSDTGAAALTGTPEKLLPTQPETGSFQVVLDDVVRAPGGRPLLDGVNQSVALGERVGIIGENGSGKSTLLRMLAGVDRPDGGQVLVRAPGGCGYLPQTPDLPPEDTVQDAIDHALAELRSLERGLREAEQALAGAEPEELEGLLGAYGDLLEAFEARDGYAADARVDAAMHGLGLAGITGDRRLGSLSGGEQARLNLACLLAASPQLMLLDEPTNHLDVGALEWLEERLRAHRGSVLVVSHDRVFLERVATALWEVDGERRTVNRHGGGYAGYLQAKAAARRRWEQAYQDWLEDLARQRELARSAADHLATGPRRNTERSNQRHQRNVEKQISARVRNAKERVRRLEENPVPRPPQPMRFRARVEGGGTVGRGGALAELYKVTVGTRLDVPSFTVDPGERILITGHNGAGKSTLLRVLAGDLAPDQGECERPERIGWLPQETEITDRQQSLLAAFAAGLPGIAEEHRGALLGFGLFRPSALGTAVGDLSTGQLRRLALARLLRDPADLLLLDEPTNHLSPALVEDLEEALAHYRGALVVVSHDRMFAQRFTGRRMHMEGGRFVE	6.33	gnl|BL_ORD_ID|1304|hsp_num:0	1388	True	loose hit with at least 95 percent identity pushed strict
scaffold_168_22 # 25635 # 25832 # -1 # ID=168_22;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.551	scaffold_168_22 	25635	25832	-	Strict	500	21.9422	aadK	100.0	3002627	protein homolog model	n/a	n/a	aminoglycoside antibiotic	antibiotic inactivation	ANT(6)	ATGTCTCGGGCAGAACGTCCGGCTCTTGGCCGCACTGAAGCACGAGTGGAACCAAGCAGCCGTCTGATGGCCGGACCCACCATTCGTGGCTTGGGTCCGTGTAGTCGGGTTCCATCCTTTCAGGATTTCGCGATGCTGAATGAGGCGCGCATAAATCAAAGATGCAACGATTTCGCACTCAATGATGAGAGAGAGTAA	MSRAERPALGRTEARVEPSSRLMAGPTIRGLGPCSRVPSFQDFAMLNEARINQRCNDFALNDERE	MRSEQEMMDIFLDFALNDERIRLVTLEGSRTNRNIPPDNFQDYDISYFVTDVESFKENDQWLEIFGKRIMMQKPEDMELFPPELGNWFSYIILFEDGNKLDLTLIPIREAEDYFANNDGLVKVLLDKDSFINYKVTPNDRQYWIKRPTAREFDDCCNEFWMVSTYVVKGLARNEILFAIDHLNEIVRPNLLRMMAWHIASQKGYSFSMGKNYKFMKRYLSNKEWEELMSTYSVNGYQEMWKSLFTCYALFRKYSKAVSEGLAYKYPDYDEGITKYTEGIYCSVK	22.89	gnl|BL_ORD_ID|397|hsp_num:0	426	True	loose hit with at least 95 percent identity pushed strict
scaffold_202_13 # 18193 # 18369 # -1 # ID=202_13;partial=00;start_type=ATG;rbs_motif=AGxAGG/AGGxGG;rbs_spacer=5-10bp;gc_cont=0.469	scaffold_202_13 	18193	18369	-	Strict	1000	21.1718	tva(A)	100.0	3004730	protein homolog model	n/a	n/a	macrolide antibiotic; lincosamide antibiotic; streptogramin antibiotic; tetracycline antibiotic; oxazolidinone antibiotic; phenicol antibiotic; pleuromutilin antibiotic	antibiotic target protection	ABC-F ATP-binding cassette ribosomal protection protein	ATGAGTCAAATTGTATTGGCATGGATTCTGAAGCGAGTCACGAGCCCTATCATTGGATTCAGTAGTATTGAAAGGCTTGAAGAGGCTTTATCCGCGCGTGGGAAGGAACTCACGGACGAAGAAGAGAGGTATCTCGAAGAGTTATATGTGCCGCTTGATGTGGAGGGTCACTTCTGA	MSQIVLAWILKRVTSPIIGFSSIERLEEALSARGKELTDEEERYLEELYVPLDVEGHF	MFIKFNKVSFSYDSSDNILNDVSFHIDNSCTAIVGENGCGKTTLAKLITGILKPNSGSIEYSNKNIITAYCDQECINLPDNAENLFYDDSSYSGYLTSIFKIDYNYLYRFDTLSFGERKRLQIASALYSNPDILVLDEPTNHIDIECKDILINVIKRLDCIVIIISHDIDFLDELVEKCIFIRNGNCKIRIGNYTQCRGYEKDEEDYNFSLYEESRKKAKILENRYKKLQNESDAKKSKCGSKRHIDKKDHDAKGKIDAARLAGKDSRLATKAKQAKSLYNNTVMEMESLYTKKREVMDMEFIGERYKGKFLFYLEAGETKINSIVLRHPELIVKKDSRIGIEGVNGAGKTSLLNYIIETMYDNSIDKEKIIYIPQDIDRESWNNTFNNIKALDHESLGFLMSFVNRLGSNAKSVINSLNHSPGEMRKIMLGMAVIKKPYIIMLDEPTNHLDIDSIERLEEALISFNCALIIVSHNRNFIKNAVNTLWSIKIEYNYSILDIKNTI	11.49	gnl|BL_ORD_ID|2321|hsp_num:0	3484	True	loose hit with at least 95 percent identity pushed strict
